Aldeyra Therapeutics Announces PDUFA Extension of the New Drug Application of Reproxalap for the Treatment of Dry Eye Disease – Company Announcement - FT.com
Aecom · SERVICES-ENGINEERING SERVICES · Now $72.25
-27% since the alert
$98.35 → $72.25
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS